108 related articles for article (PubMed ID: 38843072)
1. Letter to the Editor from Andereggen and Christ: "Clinical Characteristics and Outcomes of Prolactinomas in Children and Adolescents: A Large Retrospective Cohort Study".
Andereggen L; Christ E
J Clin Endocrinol Metab; 2024 Jun; ():. PubMed ID: 38843072
[No Abstract] [Full Text] [Related]
2. Response to Letter to the Editor from Andereggen and Christ: "Clinical Characteristics and Outcomes of Prolactinomas in Children and Adolescents: A Large Retrospective Cohort Study".
Wang L; Zhu H
J Clin Endocrinol Metab; 2024 Jun; ():. PubMed ID: 38843073
[No Abstract] [Full Text] [Related]
3. Clinical Characteristics and Outcomes of Prolactinomas in Children and Adolescents: A Large Retrospective Cohort Study.
Yang Y; Ke X; Duan L; Yang H; Gong F; Pan H; Wang L; Zhu H
J Clin Endocrinol Metab; 2024 Jan; ():. PubMed ID: 38164002
[TBL] [Abstract][Full Text] [Related]
4. Letter to the Editor From Lukas Andereggen: "Pitfalls in Performing and Interpreting Inferior Petrosal Sinus Sampling: Personal Experience and Literature Review".
Andereggen L; Beck J; Gralla J; Luedi MM; Christ E
J Clin Endocrinol Metab; 2021 Jul; 106(8):e3283-e3284. PubMed ID: 33982108
[No Abstract] [Full Text] [Related]
5. Response to Letter to the Editor From Lukas Andereggen: "Pitfalls in Performing and Interpreting Inferior Petrosal Sinus Sampling: Personal Experience and Literature Review".
Perlman JE; Weil RJ; Hui F; Recinos PF; Gallia G; Mukherjee D; Salvatori R; Kennedy L; Hamrahian AH
J Clin Endocrinol Metab; 2021 Jul; 106(8):e3291-e3292. PubMed ID: 33982078
[No Abstract] [Full Text] [Related]
6. Clinical, Hormonal, and Neuroradiological Characteristics and Therapeutic Outcomes of Prolactinomas in Children and Adolescents at a Single Center.
Yang A; Cho SY; Park H; Kim MS; Kong DS; Shin HJ; Jin DK
Front Endocrinol (Lausanne); 2020; 11():527. PubMed ID: 32849307
[No Abstract] [Full Text] [Related]
7. Clinical Features and Response to Treatment of Prolactinomas in Children and Adolescents: A Retrospective Single-Centre Analysis and Review of the Literature.
Breil T; Lorz C; Choukair D; Mittnacht J; Inta I; Klose D; Jesser J; Schulze E; Bettendorf M
Horm Res Paediatr; 2018; 89(3):157-165. PubMed ID: 29455199
[TBL] [Abstract][Full Text] [Related]
8. Outcome of Dopamine Agonist Therapy Withdrawal in Children with Prolactinomas.
Almutlaq N; Eugster EA; Nabhan Z; Donegan D
Horm Res Paediatr; 2022; 95(3):291-295. PubMed ID: 35609555
[TBL] [Abstract][Full Text] [Related]
9. Response to Letter to the Editor: "High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment?".
Espinosa-Cárdenas E; Sánchez-García M; Ramírez-Rentería C; Mendoza-Zubieta V; Sosa-Eroza E; Mercado M
Endocrine; 2021 Jan; 71(1):263-264. PubMed ID: 33475976
[No Abstract] [Full Text] [Related]
10. Clinical Features, Therapeutic Trends, and Outcome of Giant Prolactinomas: A Single-Center Experience Over a 12-Year Period.
Almalki MH; Aljohani N; Alzahrani S; Almohareb O; Ahmad MM; Alrashed AA; Alshahrani F; Mahmood Buhary B
Clin Med Insights Endocrinol Diabetes; 2020; 13():1179551420926181. PubMed ID: 32547285
[TBL] [Abstract][Full Text] [Related]
11. Surgical management considerations in cystic prolactinomas-a single center case series.
Nevzati E; Chatain GP; Carr SB; Lillehei KO; Kerr JM
Endocrine; 2020 Jan; 67(1):58-66. PubMed ID: 31773633
[TBL] [Abstract][Full Text] [Related]
12. Women with prolactinomas presented at the postmenopausal period.
Shimon I; Bronstein MD; Shapiro J; Tsvetov G; Benbassat C; Barkan A
Endocrine; 2014 Dec; 47(3):889-94. PubMed ID: 24711223
[TBL] [Abstract][Full Text] [Related]
13. The Prolactin per Unit Tumor Volume Ratio Accurately Distinguishes Prolactinomas From Secondary Hyperprolactinemia due to Stalk Effect.
Faje A; Jones P; Swearingen B; Tritos NA
Endocr Pract; 2022 Jun; 28(6):572-577. PubMed ID: 35339688
[TBL] [Abstract][Full Text] [Related]
14. Our experience in prolactinomas larger than 60mm.
Remón-Ruiz P; Venegas-Moreno E; Dios Fuentes E; Matias Kaen A; Cardenas Ruiz-Valdepeñas E; Martin-Schrader I; Roldán F; Fajardo E; Cano D; Soto-Moreno A
Endocrinol Diabetes Nutr (Engl Ed); 2021 Jan; 68(1):3-10. PubMed ID: 32861621
[TBL] [Abstract][Full Text] [Related]
15. Operative treatment of cystic prolactinomas: a retrospective study.
Su W; He K; Yang Y; Xu J; Li X; Tang H; Yang J; Yang L
BMC Endocr Disord; 2023 May; 23(1):99. PubMed ID: 37143054
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptives and prolactinomas: a case-control study.
Maheux R; Jenicek M; Cleroux R; Beauregard H; De Muylder X; Gratton NM; Van Campenhout J
Am J Obstet Gynecol; 1982 May; 143(2):134-8. PubMed ID: 7081323
[TBL] [Abstract][Full Text] [Related]
17. T2-weighted magnetic resonance imaging characterization of prolactinomas and association with their response to dopamine agonists.
Burlacu MC; Maiter D; Duprez T; Delgrange E
Endocrine; 2019 Feb; 63(2):323-331. PubMed ID: 30267354
[TBL] [Abstract][Full Text] [Related]
18. Transsphenoidal surgery for prolactinomas in male patients: a retrospective study.
Su WJ; Cai HC; Yang GC; He KJ; Wu HL; Yang YB; Tang HX; Yang LX; Deng CH
Asian J Androl; 2023; 25(1):113-118. PubMed ID: 35645047
[TBL] [Abstract][Full Text] [Related]
19. Prolactinomas in infertile women: clinical and endocrine characteristics before and after 24 months of treatment with bromocriptine.
Hajder M; Hajder E; Dervisefendic M; Samardzic R; Alic E
Med Arch; 2013; 67(3):181-4. PubMed ID: 23848038
[TBL] [Abstract][Full Text] [Related]
20. The Babinski sign in Renaissance paintings-a reappraisal of the toe phenomenon in representations of the Christ Child: observational analysis.
Sellal F; Tatu L
BMJ; 2020 Dec; 371():m4556. PubMed ID: 33303424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
